Chris Boshoff, Senior Vice President of Immuno-Oncology, Translational and Early Development at Pfizer, and colleagues Samra Turajlic and Charles Swanton from the Francis Crick Institute and University College London give us their personal point of view on new insights and future therapeutic approaches for renal cancer.
The Journal of experimental medicine. 2018 Sep 14 [Epub]
Samra Turajlic, Charles Swanton, Chris Boshoff
Francis Crick Institute, London, UK., Pfizer Inc., New York, NY .